Search

Vista Pharmaceuticals

Sector: Healthcare | Industry: Drugs & Pharma
R 42.00 -0.35  | -0.83% 142.77% 78.28 120.32
BSE Price: Dec 15, 2017 Change R    |  % 1-Year Change P/E Market Cap (R Cr)
BSE Dec 15, 2017 42.00 -0.35 -0.83% 40.25 42.35 13,638 40.25 - 43.25
Exchange & Time Last Price      Day Change Open Prev Close Volume    1-Day Range
GET STOCK UPDATES FROM VALUE RESEARCH IN YOUR INBOX
6M Average Volume: 66,917 P/B: 4.97 NSE Code:
52-Week Range: R 15.85 - 54.15 Dividend Yield: 0.00% BSE Code: 524711
TTM EPS: R 0.54 Book Value: R 8.44 Face Value: R 2
Price Graph
  • Caplin Point Laboratories (BSE)
  • S&P BSE Sensex


Please wait while we are fetching data...
Get the best stock ideas
Want to create meaningful wealth through stock investing? Subscribe to Wealth Insight
Performance
  YTD 1-Month 3-Month 1-Year 3-Year 5-Year 10-Year
Vista Pharmaceuticals 135.29 5.40 -11.02 142.77 52.11 50.07 10.43
S&P BSE Small Cap 50.84 5.19 8.89 49.63 18.20 19.81 4.06
S&P BSE Healthcare -4.70 3.60 1.98 -7.73 -1.94 11.94 12.52
Company's return has been calculated on basis of BSE's price.
As on Dec 15, 2017
Key Ratios
Revenue Per Share (R) Earnings Per Share (R) Return on Networth (%)


Please wait
while we are fetching data...


Please wait
while we are fetching data...


Please wait
while we are fetching data...
Annual Ratios (%)
  1-Year 3-Years 5-Years
Growth
Revenue 57.23 42.82 46.18
Net Profit 48.73 35.11 21.91
EPS 39.91 11.66 19.04
Book Value 35.47 0.06 1.29
Average
Operating Margin 12.81 16.54 15.14
Net Margin 4.75 6.56 5.27
Return on Networth 8.42 9.84 7.14
Return on Investment 8.93 10.89 8.02
Interim Growth Ratios (%)
  QoQ YoY YTD
Quarterly
Revenue -8.16 12.44 9.55
Operating Profit 30.84 103.19 137.82
Net Profit 52.74 79.53 507.92
EPS 42.87 56.65 463.95
TTM
Revenue 2.89 17.93 9.18
Operating Profit 22.79 15.93 40.28
Net Profit 21.50 361.56 29.70
EPS 15.73 328.15 20.93
Peer Comparison
  Market Cap
(R Cr)
Revenue
(R Cr)
Net Profit
(R Cr)
Net Margin (%) RoE (%) Price to Book Price to Earnings
Vista Pharmaceuticals 120.32 26.40 1.54 5.66 8.42 4.97 78.28
Caplin Point Laboratories 4,821.04 478.14 129.08 26.36 56.14 16.97 37.31
FDC 3,726.49 1,025.95 165.24 15.41 16.02 2.85 22.55
Insider Trades
Date Person  Buy / Sell Transaction
Type
No of Shares Price
(R)   
Value
(R Lakhs)
Sep 18, 2017 Keshava Murthy Shiva Shankar  Sell Market 900,500 45.75 411.98
Apr 03, 2017 Vista Pharmaceuticals Inc  Buy Preferential Allotment 1,571,286 37.00 581.38
Mar 06, 2017 Gopal Dasari  Sell Market 2,671,666 34.95 933.75
Mar 06, 2017 Pradeep Kumar Samala  Sell Market 1,900,000 34.95 664.05
News & Announcements
Contact Information

Company: Vista Pharmaceuticals Ltd.

Address: Plot Nos.10 To 14 And 16 To 20, A P I I C Industrial Estate, Gopalaipalli Village, Narketpally Mandal, Nalgonda Dist, Gopalaipalli, Andhra Pradesh - 508254 | Phone: 08682- 272552 / 09291015956 | Fax: 08682- 272551

Email: [email protected]

Website: www.vistapharmaceuticals.com

Registrar & Transfer Agent: Aarthi Consultants Pvt Ltd

Address: 1-2-285, Domalaguda, Hyderabad | Phone: 040-7642217/7634445 | Fax: 040-7632184

comments powered by Disqus
Essential checks
Altman Z-Score
4.47
Piotroski F-Score
5
Modified C-Score
4
1-Year Price to Earnings
78.93
1-Year Price to Book
5.02
Earnings Yield
EBIT / Enterprise value
2.61%
PEG
Price / Earnings to growth ratio
0.17
Related Stocks
  Current Price   Chng %
Astrazeneca Pharma India R1,126.10 +0.81%
Caplin Point Laboratories R638.25 -0.11%
FDC R209.80 -1.15%
Granules India R126.80 +0.20%
Indoco Remedies R275.50 -1.18%
JB Chemicals & Pharma R295.10 -0.08%
Poly Medicure R273.95 -0.58%
Sequent Scientific R98.95 +0.82%
Suven Life Sciences R184.75 +0.22%
Unichem Laboratories R305.00 +1.99%
As on Dec 15, 2017